Houston, TX 的 肺部疾病 臨床試驗
15 項針對 肺部疾病 的研究正在 Houston（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of COVID-19 Vaccine(s) in Children and Adults
招募中3 期歡迎健康志工
- DM Clinical Research-Cyfair, Houston
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
招募中3 期
- Memorial Hermann Hospital TMC, Houston
- The University of Texas Health Science Center at Houston, Houston
- UT Physicians, Houston
- 還有 4 項
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
招募中3 期
- Cockrell Center for Advanced Therapeutics, Houston
- Houston Methodist - Transplant Center, Houston
- Houston Methodist Hospital, Houston
- 還有 4 項
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
招募中2 期
- Baylor College of Medicine Medical Center, Houston
American Lung Association (ALA) Lung Health Cohort
招募中觀察性研究歡迎健康志工
- Baylor College of Medicine, Houston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- MD Anderson, Houston
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
招募中2 期
- Greater Heights & Memorial Pulmonary and Sleep, Houston
- Houston Pulmonary Sleep and Allergy Associates, Houston
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
招募中1/2 期
- Site 1005, Houston
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
招募中3 期
- GSK Investigational Site, Houston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
招募中3 期
- Houston Methodist Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
- Lumi Research, Houston
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
招募中2 期
- Baylor College of Medicine, Houston
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
招募中2 期
- Clinical Research Site, Houston
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
招募中2 期
- University of Texas MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
招募中1/2 期
- MD Anderson Cancer Center, Houston
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
招募中
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
其他城市的 肺部疾病 試驗
- Boston, MA14 項研究
- Durham, NC13 項研究
- New York City, NY12 項研究
- Pittsburgh, PA11 項研究
- Los Angeles, CA10 項研究
- Columbus, OH10 項研究
- Dallas, TX10 項研究
- Nashville, TN10 項研究
- Washington, DC10 項研究
- Miami, FL10 項研究
- Ann Arbor, MI10 項研究
- Chicago, IL9 項研究
Houston 的其他研究
- 非小細胞肺癌145 項研究
- 乳癌126 項研究
- 癌症（所有類型）121 項研究
- 轉移性癌症104 項研究
- 大腸直腸癌102 項研究
- 卵巢癌89 項研究
- 急性髓系白血病85 項研究
- 肺癌78 項研究
- 前列腺癌76 項研究
- 子宮內膜癌68 項研究
- 胰臟癌61 項研究
- 黑色素瘤59 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。